Scientists Lament Lowell Weicker's Election Defeat

WASHINGTON—Elections are supposed to bring change. But the November 8 vote that denied Sen. Lowell Weicker (R-Conn.) a fourth term in office was not the sort of change scientists had in mind. “I have to talk through my tears,” laments lobbyist Lynn Morrison of the American Federation for Clinical Research. “Losing Lowell Weicker from the Senate is going to be tough for the entire biomedical community.” Weicker’s narrow defeat at the hands of Connecticut&#

Written byJeffrey Mervis
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WASHINGTON—Elections are supposed to bring change. But the November 8 vote that denied Sen. Lowell Weicker (R-Conn.) a fourth term in office was not the sort of change scientists had in mind. “I have to talk through my tears,” laments lobbyist Lynn Morrison of the American Federation for Clinical Research. “Losing Lowell Weicker from the Senate is going to be tough for the entire biomedical community.”

Weicker’s narrow defeat at the hands of Connecticut’s Attorney General Joseph Lieberman was the most dramatic of a number of election results affecting science (see story, page 27). And it was a decid edly unpleasant reminder to the scientific community not to become complacent when counting up its friends in Congress.

A maverick liberal Republican, Weicker was a tireless advocate for increased health funding. Sometimes he lost. Last year, for example, he failed in an ambitious effort to transfer $200 million from the defense ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies